Article content material
NEWCASTLE, Wash., May 17, 2024 (GLOBE NEWSWIRE) — Roger Greene has filed an early warning report (the “Report”) relating to his holdings in Evome Medical Technologies Inc. (the “Issuer”).
Pursuant to the Issuer’s Annual Report on Form 10-Okay for the fiscal yr ended December 31, 2023, which was filed by the Issuer with securities regulators on April 16, 2024, the Issuer disclosed that it had 21,056,409 Class “A” non-voting frequent shares (the “Class A Shares”) issued and excellent as of April 9, 2024. As a end result, as of at the least April 9, 2024, Roger Greene ceased to carry at the least 10% of the Class A Shares.
Article content material
Accordingly, as of at the least April 9, 2024, the Roger Greene’s securityholdings and share within the Class A Shares decreased from 600,000 (44.3%) to 600,000 (2.8%) on each a non-diluted and partially diluted foundation, and Mr. Greene has filed an early warning report (Form 62-103F1).
Mr. Greene might enhance or scale back his funding within the Issuer based on market situations or different related elements.
For additional particulars regarding the acquisition, please see the Report, which was filed in accordance with relevant securities legal guidelines, a duplicate of which is obtainable underneath the Issuer’s profile on the SEDAR+ web site at www.sedarplus.com, or could also be obtained from Mr. Greene by contacting (202) 670-7505.
Share this text in your social community